Logo image of PALI.CA

PALISADES GOLDCORP LTD (PALI.CA) Stock Fundamental Analysis

Canada - TSX-V:PALI - CA69639F1009 - Common Stock

1.65 CAD
+0.01 (+0.61%)
Last: 9/23/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to PALI. PALI was compared to 80 industry peers in the Capital Markets industry. PALI has a great financial health rating, but its profitability evaluates not so good. PALI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

PALI had negative earnings in the past year.
In the past year PALI has reported a negative cash flow from operations.
In multiple years PALI reported negative net income over the last 5 years.
PALI had a negative operating cash flow in each of the past 5 years.
PALI.CA Yearly Net Income VS EBIT VS OCF VS FCFPALI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

PALI has a Return On Assets of -91.11%. This is amonst the worse of the industry: PALI underperforms 87.50% of its industry peers.
PALI has a Return On Equity of -103.33%. This is amonst the worse of the industry: PALI underperforms 86.25% of its industry peers.
Industry RankSector Rank
ROA -91.11%
ROE -103.33%
ROIC N/A
ROA(3y)-47.42%
ROA(5y)-16.52%
ROE(3y)-60.46%
ROE(5y)-19.18%
ROIC(3y)N/A
ROIC(5y)N/A
PALI.CA Yearly ROA, ROE, ROICPALI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

PALI's Profit Margin has declined in the last couple of years.
The Profit Margin and Operating Margin and Gross Margin are not available for PALI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-7.55%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PALI.CA Yearly Profit, Operating, Gross MarginsPALI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 1K -1K 2K

9

2. Health

2.1 Basic Checks

PALI has less shares outstanding than it did 1 year ago.
There is no outstanding debt for PALI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PALI.CA Yearly Shares OutstandingPALI.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M
PALI.CA Yearly Total Debt VS Total AssetsPALI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 4.80 indicates that PALI is not in any danger for bankruptcy at the moment.
PALI has a better Altman-Z score (4.80) than 81.25% of its industry peers.
There is no outstanding debt for PALI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.8
ROIC/WACCN/A
WACCN/A
PALI.CA Yearly LT Debt VS Equity VS FCFPALI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 95.57 indicates that PALI has no problem at all paying its short term obligations.
PALI's Current ratio of 95.57 is amongst the best of the industry. PALI outperforms 98.75% of its industry peers.
A Quick Ratio of 95.57 indicates that PALI has no problem at all paying its short term obligations.
PALI has a better Quick ratio (95.57) than 98.75% of its industry peers.
Industry RankSector Rank
Current Ratio 95.57
Quick Ratio 95.57
PALI.CA Yearly Current Assets VS Current LiabilitesPALI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1

3. Growth

3.1 Past

PALI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -183.11%.
PALI shows a strong growth in Revenue. In the last year, the Revenue has grown by 89.29%.
EPS 1Y (TTM)-183.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-655.41%
Revenue 1Y (TTM)89.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%765.99%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PALI.CA Yearly Revenue VS EstimatesPALI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 0 50M 100M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PALI. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PALI.CA Price Earnings VS Forward Price EarningsPALI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PALI.CA Per share dataPALI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

PALI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PALISADES GOLDCORP LTD

TSX-V:PALI (9/23/2025, 7:00:00 PM)

1.65

+0.01 (+0.61%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.21%
Inst Owner ChangeN/A
Ins Owners44.65%
Ins Owner ChangeN/A
Market Cap106.38M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.06
P/tB 1.06
EV/EBITDA N/A
EPS(TTM)-2.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS-0.01
BVpS1.56
TBVpS1.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -91.11%
ROE -103.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-47.42%
ROA(5y)-16.52%
ROE(3y)-60.46%
ROE(5y)-19.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-7.55%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover-0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 95.57
Quick Ratio 95.57
Altman-Z 4.8
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-183.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-655.41%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)89.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%765.99%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y70.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y39.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y39.38%
OCF growth 3YN/A
OCF growth 5YN/A